117
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 315-323 | Received 28 Feb 2023, Accepted 29 Mar 2023, Published online: 26 Apr 2023

References

  • National Institute of General Medical Sciences . Pharmacogenomics. https://nigms.nih.gov/education/fact-sheets/Pages/pharmacogenomics.aspx
  • Olson JE , RohrerVitek CR , BellEJet al. Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time). Genet. Med.19(7), 819–825 (2017).
  • Lautenbach DM , ChristensenKD , SparksJA , GreenRC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu. Rev. Genom. Hum. Genet.14(1), 491–513 (2013).
  • Hibbard JH , StockardJ , MahoneyER , TuslerM. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers: development of the patient activation measure (PAM). Health Serv. Res.39(4 pt 1), 1005–1026 (2004).
  • Jones LK , KulchakRahm A , GionfriddoMRet al. Developing pharmacogenomic reports: insights from patients and clinicians. Clin. Transl. Sci.11(3), 289–295 (2018).
  • Truong TM , LipschultzE , SchiererE , DanaheyK , RatainMJ , O’DonnellPH. Patient insights on features of an effective pharmacogenomics patient portal. Pharmacogenet. Genomics30(9), 191–200 (2020).
  • Bruno B , SteeleS , CarboneJ , SchneiderK , PoskL , RoseSL. Informed or anxious: patient preferences for release of test results of increasing sensitivity on electronic patient portals. Health Technol.12(1), 59–67 (2022).
  • Office of the National Coordinator for Health Information Technology . About ONC’s Cures Act Final Rule. www.healthit.gov/curesrule/overview/about-oncs-cures-act-final-rule
  • Hajek C , HutchinsonAM , GalbraithLNet al. Improved provider preparedness through an 8-part genetics and genomic education program. Genet. Med.24(1), 214–224 (2022).
  • Christensen KD , BellM , ZawatskyCLBet al. Precision population medicine in primary care: the Sanford Chip experience. Front. Genet.12, 626845 (2021).
  • Natasha Petry , BayeJ , AifaouiAet al. Implementation of wide-scale pharmacogenetic testing in primary care. Pharmacogenomics20(12), 903–913 (2019).
  • Kelly DV , YoungS , PhillipsL , ClarkD. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can. Pharm. J.147(4), 239–247 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.